Serum albumin as a prognostic indicator for HIV disease progression

AIDS Research and Human Retroviruses

Volumn 22, Issue 1, 2006, Pages 14-21

  Mehta, Shruti H ^a   Astemborski, Jacquie ^a   Sterling, Timothy R ^b   Thomas, David L ^a,c   Vlahov, David ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; SERUM ALBUMIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SEROCONVERSION; UNITED STATES;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SERUM ALBUMIN; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 32044436478     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.14     Document Type: Article

References (22)

1. Mellors JW, Munoz A, Giorgi JV, et al.: Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-954.
2. Kim S, Hughes MD, Hammer SM, et al.: Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. AIDS Res Hum Retroviruses 2000;16:645-653.
3. Vlahov D, Graham N, Hoover D, et al.: Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: Plasma viral load and CD4+ cell count. JAMA 1998;279:35-40.
4. Chaisson RE, Taylor E, Margolick JB, et al.: Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr 1992;5:456-460.
5. Munoz A, Carey V, Saah AJ, et al.: Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1988;1:396-404.
6. Phillips AN, Sabin CA, Elford J, et al.: Serum beta 2-microglobulin at HIV-1 seroconversion as a predictor of severe immunodeficiency during 10 years of followup. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:262-266.
7. Phillips AN, Sabin CA, Elford J, et al.: CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up. AIDS 1993;7:975-980.
8. Eyster ME, Gail MH, Ballard JO, Al Mondhiry H, and Goedert JJ: Natural history of human immunodeficiency virus infections in hemophiliacs: Effects of T-cell subsets, platelet counts, and age. Ann Intern Med 1987;107:1-6.
9. Levy S, Geny A, Partisani M, Rey D, and Lang JM: Correlation between platelet number and viral load in HIV-1 infection. AIDS 1997;11:1399-1400.
10. Spacek LA, Griswold M, Quinn TC, and Moore RD: Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings. AIDS 2003;17:1311-1317.
11. Sterling TR, Hoover DR, Astemborski J, et al.: Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: Prognostic value in adults with early-stage disease. J Infect Dis 2002;186:1181-1185.
12. Kumarasamy N, Mahajan AP, Flanigan TP, et al.: Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr 2002;31:378-383.
13. Phillips A, Shaper AG, and Whincup PH: Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989;2:1434-1436.
14. Goldwasser P and Feldman J: Association of serum albumin and mortality risk. J Clin Epidemiol 1997;50:693-703.
15. Sabin CA, Griffioen A, Yee TT, et al.: Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: A longitudinal study. Lancet 2002;360:1546-1551.
16. Feldman JG, Gange SJ, Bacchetti P, et al.: Serum albumin is a powerful predictor of survival among HIV-1-infected women. J Acquir Immune Defic Syndr 2003;33:66-73.
17. Feldman JG, Burns DN, Gange SJ, et al.: Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study. AIDS 2000;14:863-870.
18. Vlahov D, Anthony JC, Munoz A, et al.: The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants. NIDA Res Monogr 1991;109:75-100.
19. Rai R, Wilson LE, Astemborski J, et al.: Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology 2002;35:1247-1255.
20. Thomas DL, Astemborski J, Rai RM, et al.: The natural history of hepatitis C virus infection: Host, viral, and environmental factors. JAMA 2000;284:450-456.
21. Feldman JG, Goldwasser P. Holman S, DeHovitz J, and Minkoff H: C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. J Acquir Immune Defic Syndr 2003;32:210-214.
22. Gabay C and Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.